罗欣药业最新股东户数环比下降9.06% 筹码趋向集中

Group 1 - The core point of the article highlights that Luoxin Pharmaceutical reported a decrease in the number of shareholders, with a total of 43,927 shareholders as of October 31, which is a reduction of 4,377 shareholders compared to the previous period, reflecting a month-on-month decline of 9.06% [2] - The closing price of Luoxin Pharmaceutical was 5.40 yuan, remaining flat, with a cumulative decline of 1.46% in stock price since the concentration of shares began, showing 5 days of increases and 8 days of decreases during this period [2] - The company's third-quarter report indicates that for the first three quarters, it achieved an operating income of 1.723 billion yuan, a year-on-year decrease of 8.37%, while net profit reached 22.93 million yuan, a year-on-year increase of 108.64%, with basic earnings per share of 0.0216 yuan and a weighted average return on equity of 1.62% [2]